Michael Desjardin Net Worth & Insider Trades

Michael Desjardin - EVP, Horizon Therapeutics Public Ltd Co

As of March 6, 2023

What is Michael Desjardin's Net Worth?

The current estimated net worth of Horizon Therapeutics Public Ltd Co's EVP, Michael Desjardin, is estimated to be about $20.68M . Michael Desjardin owns about 82,346 units of Horizon Therapeutics Public Ltd Co common stock. In the last 5 years at Horizon Therapeutics Public Ltd Co, Michael Desjardin has sold an estimated value of $25.14M worth.

What is Michael Desjardin's Past Insider Trading?

Michael Desjardin's largest purchase order was 27,106 units , worth over $443.3K on January 8, 2021. Michael Desjardin's largest sale order was 35,000 units , worth over $3.4M on March 4, 2022. In total, Michael Desjardin has made about 31 transactions over 5 years of their time at Horizon Therapeutics Public Ltd Co. Michael Desjardin usually trades in January, with the busiest year in 2021. The most recent transaction was a sale order of 20,214 units , worth over $2.29M on April 14, 2022.

Michael DesJardin

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Michael Desjardin's' Mailing Address?

  • Mailing address is C/o Jazz Pharmaceuticals, Inc. 3180 Porter Drive Palo Alto CA 94304 CA

Horizon Therapeutics Public Ltd Co Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Total
Timothy P. Walbert 2020 $1,146,542 - $199,548 $199,548 $199,548 $199,548 $21,632,803
Timothy P. Walbert 2019 $1,108,700 - $226,871 $226,871 $226,871 $226,871 $13,873,172
Timothy P. Walbert 2018 $1,076,250 - $160,363 $160,363 $160,363 $160,363 $16,796,894
Paul W. Hoelscher 2020 $600,569 - $106,485 $106,485 $106,485 $106,485 $5,915,146
Paul W. Hoelscher 2019 $580,748 - $120,135 $120,135 $120,135 $120,135 $4,443,588
Paul W. Hoelscher 2018 $563,750 - $104,332 $104,332 $104,332 $104,332 $7,034,386
Andy Pasternak 2020 $669,021 $250,000 $66,872 $66,872 $66,872 $66,872 $5,826,126
Andy Pasternak 2019 $108,333 $500,000 $19,188 $19,188 $19,188 $19,188 $2,924,542
Jeffrey W. Sherman, M.D., FACP 2020 $578,731 - $92,545 $92,545 $92,545 $92,545 $5,261,300
Jeffrey W. Sherman, M.D., FACP 2019 $559,630 - $95,222 $95,222 $95,222 $95,222 $3,568,496
Jeffrey W. Sherman, M.D., FACP 2018 $543,250 - $68,263 $68,263 $68,263 $68,263 $3,678,874
Barry J. Moze 2020 $628,960 - $75,659 $75,659 $75,659 $75,659 $5,073,877
Barry J. Moze 2019 $608,201 - $58,744 $58,744 $58,744 $58,744 $4,662,510
Barry J. Moze 2018 $590,400 - $35,114 $35,114 $35,114 $35,114 $2,732,565
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1492426/000119312521084225/d42343ddef14a.htm

What are Horizon Therapeutics Public Ltd Co's Past Insider Trades?

Horizon Therapeutics Public Ltd Co's most recent insider trade came on January 18, 2023 by Andy Pasternak who sold 27,129 units worth $3.07M . In the last 12 years, insiders at Horizon Therapeutics Public Ltd Co have sold an estimated value of $734.18M and bought an estimated value of $120.28M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Timothy Walbert, Chairman,  Jeffrey Sherman, EVP and Chief Medical Officer,  and Paul Hoelscher, EVP .

Horizon Therapeutics Public Ltd Co Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...